A survey of methylated candidate tumor suppressor genes in nasopharyngeal carcinoma

Methylation of estrogen receptor 1 in colorectal adenomas is not age-dependent, but is correlated withK-rasmutation

(2009) Joichiro Horii et al.   CANCER SCIENCE

Pharmacologic Unmasking of Epigenetically Silenced Genes in Breast Cancer

(2009) K. L. Ostrow et al.   CLINICAL CANCER RESEARCH

Focal adhesion-localization of START-GAP1/DLC1 is essential for cell motility and morphology

(2009) Katsuhisa Kawai et al.   GENES TO CELLS

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

(2009) Roger Stupp et al.   LANCET ONCOLOGY

Fragile Histidine Triad Gene Inactivation in Lung Cancer

(2008) Carla Verri et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Aberrant Promoter Methylation of Multiple Genes during Pathogenesis of Bladder Cancer

(2008) M. Brait et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Genome-Wide Promoter Analysis Uncovers Portions of the Cancer Methylome

(2008) M. O. Hoque et al.   CANCER RESEARCH

Evaluation of Promoter Hypermethylation Detection in Body Fluids as a Screening/Diagnosis Tool for Head and Neck Squamous Cell Carcinoma

(2008) A. L. Carvalho et al.   CLINICAL CANCER RESEARCH

The role of PGP9.5 as a tumor suppressor gene in human cancer

(2008) Yutaka Tokumaru et al.   INTERNATIONAL JOURNAL OF CANCER

OPCML Is a Broad Tumor Suppressor for Multiple Carcinomas and Lymphomas with Frequently Epigenetic Inactivation

(2008) Yan Cui et al.   PLoS One